Category: Thought Leadership
November 9 2016
Description of this Image

Paul H. Keckley, Ph.D., is managing editor of The Keckley Report, a health care researcher and widely known industry expert. In addition to The Keckley Report, he authors a monthly column for Hospitals & Health Networks and has published three books and 250 articles. During the period preceding the passage of the Affordable Care Act, he facilitated sessions among the White House Office of Health Reform and major health industry trade groups as private sector input was sought in the legislation.

Next week at Cerner Health Conference, Keckley will share his reflections on the election, the focus of the Trump administration and 115th Congress and the megatrends facing our industry and Health Reform 2.0.

Special Post Election Edition: Reposted from The Keckley Report

November 9, 2016

Health Reform and the Trump White House: Implications for Key Stakeholders

The election results are in, and Donald Trump will be the 45th president of the United States. His appeal to “Make America Great Again” resonated across the heartland, sparking an unprecedented political upset that surprised even the most astute prognosticators and pundits. 

When he takes office in January, he’ll face enormous challenges domestically and globally. Health care will be at the top of the list: he promised to “repeal and replace” the Affordable Care Act (ACA), and he pledged changes that strengthen the system in his campaign’s 7-point plan. In this effort, his team will face harsh realities: 

Containing health costs will continue to be the dominant issue.

Total health care spending will increase 6 percent annually for the next decade. Utilization is up. Demand is increasing and traditional reimbursement is not keeping pace with underlying costs. That’s not sustainable. Something’s got to give.

The fundamental structure of the health system is shifting. 

Health care is no longer a cottage industry. Mega deals across the board are pending, like Anthem-Cigna, Aetna-Humana and more. And in most communities, half of the physicians are employed by hospitals that are affiliated with multi-hospital systems. The health system’s future will play out against new ways of competing.

Alternative payment programs (APMs) are changing incentives for providers. 

With MACRA payments to physicians and mandated bundled payments for heart failure, coronary artery surgery and joint replacements for hospitals coming on line next year, providers are anxious. What’s next? What’s their future?

Competition from non-traditional entrants is increasing. 

Investors are flocking to startups that challenge the status quo in health care. Their ranks include retail clinics, micro hospitals, telemedicine, urgent care centers, disposables, smart implantables, hybrid insurance models and others that challenge stakeholders to innovate faster and more effectively. It’s a huge industry that’s historically made its own rules and kept outsiders out. That’s changing.

The public is divided about the ACA.

Half believe it a necessary impetus for expanding insurance coverage and lower costs, and half feel it’s an overreach by federal bureaucrats that want a government-run health system. 

The Trump Agenda for the Health System: Repeal and Replace the ACA.

Details about the Trump health care agenda are not clear, but the campaign promised to repeal and replace the ACA on his first day in office. With majorities in both houses of Congress, the vehicle whereby the law can be changed is straightforward: the bigger questions are how it is to be replaced.

After the vote, it’s likely a series of administrative orders and targeted legislation will follow that begin the process of undoing the ACA including,

  • Dismantling Health care.gov and transitioning control of the marketplaces to the states. 
  • Negotiating with Congressional budget officers and HHS for the transfer of Medicaid responsibility to the states via block grants.
  • Expanding tax credits and high risk pools for individuals and allowing purchases of insurance across state lines.
  • And through legislative negotiations, transitioning oversight and subsidies for its 12 million newly insured to states over a period of several months. 

It’s likely the Trump team will advance other proposals, like allowing for the importation of prescription drugs, but the mechanisms whereby these are enacted is problematic. 

The first 100 days: appointments, deals and posturing

The first 100 days of an administration are marked by three major activities: 1, political appointments to the cabinet, key agencies and programs; 2, deals with Congress to set a tone for lawmaking to see who’s in charge; and 3, posturing to garner public opinion gains.

Appointments: A new administration has 4,000 political appointments to make, including more than 200 in key health care slots. Since cooperation with states will be central to the new administration’s health strategy, the HHS cabinet position is likely to be filled by a former Republican governor with state health care officials filling many of the key slots. Dr. Ben Carson, a former presidential candidate himself, is likely to play a key role along with other campaign operatives in their selection. 

Deals: The new administration and Congress will advance bills to eliminate the Cadillac tax on employers and medical device tax as a start. With the composition of a supportive Congress, the low-hanging fruit includes ways to improve veteran’s health programs and potentially legislation to control drug prices.

Posturing: The honeymoon for a new administration is short, particularly one elected in a bitter campaign season in which distrust for the leading candidates was the central issue. The Trump team is unknown on Capitol Hill, so uncertainty abounds. Confirmation of cabinet appointments will surface how battle lines are drawn. The confirmation of the Supreme Court vacancy left by the death of Justice Scalia will be huge, symbolically, as ideologues flex their muscles. 

Campaign 2016 was far from ordinary. There remain many unknowns, especially about health care.

Implications for Key Stakeholders

So, what does all this mean for the stakeholders in the industry — the providers of services, the intermediaries who organize networks and negotiate rates, and the manufacturers of the drugs, technologies and “stuff” we use?

  • It means the role of federal and state oversight will change in every aspect of our businesses. 
  • It means cost containment will be table stakes as margins shrink. Health care spending will increase, but at a slower pace. There will be winners and losers in every sector.
  • It means the line between financing and delivering care will fade as providers take on responsibility for insurance and affordability. Hospitals will become systems of health.
  • It means the gaps between health services and human services and between physical and mental health will narrow as health is redefined.

Campaign 2016 is now history. President-elect Trump’s business savvy will no doubt be the underlying theme of his administration. It will be put to the test at home and abroad, and especially in our health care system. 

Paul Keckley,Ph.D.

Paul Keckley Ph.D. The Keckley Report

@paulkeckley

More from Cerner

Top Hit Blogger_Healthcare IT Leaders
;